Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New acne treatments show promise as alternatives to traditional therapies.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

TNF-alpha inhibitors can cause various immune-related skin issues.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Alopecia areata does not affect areas with psoriasis plaques.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Certain gene variations may increase the risk and severity of alopecia areata.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

People with vitiligo may have a lower risk of heart disease.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.